Filter
1778
Filtered Results: 1778
Text search:
molecular
Featured
Recommendations
205
New Publications
331
Language
Document type
No document type
780
Guidelines
394
Studies & Reports
317
Manuals
103
Strategic & Response Plan
76
Fact sheets
53
Training Material
19
Situation Updates
17
Resource Platforms
9
Infographics
7
Videos
2
Brochures
1
Countries / Regions
India
95
Latin America and the Carribbean
70
Global
62
Brazil
61
Western and Central Europe
60
Africa
39
Eastern Europe
36
Germany
34
Kenya
30
Colombia
30
South Africa
28
Ethiopia
22
Tanzania
22
Peru
22
Argentina
20
West and Central Africa
20
Venezuela
20
Russia
18
East and Southern Africa
17
El Salvador
16
Paraguay
15
Uganda
14
Mozambique
14
South–East Asia Region
14
Sierra Leone
13
Bolivia
13
Nigeria
12
Malawi
12
Senegal
11
Philippines
11
Rwanda
11
Nepal
10
Angola
10
Asia
10
Congo, Democratic Republic of
9
Zambia
9
Ukraine
9
Ecuador
9
Chile
9
Liberia
8
Indonesia
8
Middle East and North Africa
8
Ghana
7
Bangladesh
7
Namibia
7
Spain
7
Zimbabwe
6
Syria
6
Myanmar / Burma
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Guinea-Bissau
4
USA
4
Cameroon
4
Haiti
4
Pakistan
4
Italy
4
Vietnam
4
France
4
Guinea
3
Burkina Faso
3
Lebanon
3
Cambodia
3
Benin
3
Eswatini/ Swaziland
3
Botswana
3
Uruguay
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Niger
2
Somalia
2
South Sudan
2
Iraq
2
Jordan
2
Turkey
2
Chad
2
Thailand
2
China
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Tajikistan
2
Georgia
2
North America
2
United Kingdom
2
Portugal
2
Morocco
1
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
North Macedonia
1
Switzerland
1
Cuba
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Yemen
1
Palestine
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
615
Clinical Guidelines
223
Public Health
76
Pharmacy & Technologies
65
Key Resources
29
Women & Child Health
23
Capacity Building
6
Toolboxes
TB
389
COVID-19
279
AMR
113
NTDs
111
HIV
86
Rapid Response
78
Mental Health
78
Ebola
46
Planetary Health
46
Zika
33
Pharmacy
31
NCDs
27
Refugee
21
Polio
14
Caregiver
14
Specific Hazards
11
Cholera
10
Global Health Education
9
Disability
8
Health Financing Toolbox
6
Conflict
5
Natural Hazards
4
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustments that, if implemented rapidly and consistently at ...
Orientations provisoires
9 août 2021
Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractér...
Orientaciones provisionales
9 de agosto de 2021
El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades pa...
La détection directe des protéines virales du SRAS-CoV-2 (antigènes) dans les écouvillons nasaux et autres sécrétions respiratoires à l'aide de tests immunologiques à flux latéral (également appelés tests de diagnostic rapide, TDR) offre une méthode plus rapide et moins coûteuse pour te...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
SBMFC Recommendations for PHC during the Pandemic of COVID-19 (edition 4)
This document answers questions and gives recommendations so that the Brazilian PHC can quickly receive the best possible scientific synthesis on the current situation of the pandemic of COVID-19
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Key questions
What is already known?
Critical illness is common throughout the world and COVID-19 has caused a global surge of critically ill patients.
There are large gaps in the quality of care for critically ill patients, especially in low-staffed and low-resourced settings, and mortal...
Methodology for evaluating national national arboviral disease prevention and and control of arboviral diseases in the Americas
A rapid review of evidence on the managing the risk of disease emergence in the wildlife trade - World Animal Health Organization (OIE)
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission;
Sentinel surveillance in high-risk populations to detect ...
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
COVID - 19 and PREGNANCY
Management guidelines for SARS-CoV-2 infection
